Avni Finn

Associate Professor

Vanderbilt University School of Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (14)

Purpose: To use time-driven activity-based costing to calculate the complete cost profile of new uveitis patient visits. Methods: A multicenter cohort of consecutive patients referred for new uveitis evaluation, including all anatomic locations of uveitis, was included for economic analysis. Process flow mapping, electronic health record time logs, and manual validation were used for time-driven activity-based costing analysis. Imaging time and resources, which are billed separately, were excluded. Results: Time-driven activity-based costing analysis of new uveitis patient visits resulted in an average total cost of $550.50 per visit, including $56.78 of overhead (95% CI, $493.74 to $607.27). On average, patient visits required 36.6 minutes of physician time pre-visit, 30.1 minutes during the visit, and 31.7 minutes post-visit. Relative to Medicare reimbursement, the average cost resulted in losses of $325.78 for Current Procedural Terminology (CPT) code 99205 and $380.16 for CPT code 99204. The G2211 add-on CPT code compensated for 3.23 minutes of in-visit physician time. Conclusions: The cost of new uveitis patient visits exceeds maximum Medicare reimbursement in both academic and private practice settings. These findings may inform policy discussions on reimbursement to better reflect the time and expertise required for complex uveitis patient evaluation and management.

Year:

2026

Year:

2026

Year:

2026

Purpose: To investigate the relationship between preoperative volumetric optical coherence tomography (OCT) features of full-thickness macular holes (FTMHs), including intraretinal cysts and 3-dimensional hole symmetry, and both visual acuity outcomes and surgical prognosis in patients with FTMH. Methods : This multicenter, retrospective cohort study assessed patients with FTMH who underwent pars plana vitrectomy from 2017 to 2022. In-depth manual segmentation of each pre- and postoperative OCT volumetric scan (60 B-scans per volume) was performed by 3 graders. Correlations between preoperative cystoid volume and FTMH symmetry and preoperative visual acuity, preoperative minimum linear diameter (MLD), improvement in visual acuity at 6 months postsurgery, and FTMH closure rate postsurgery were assessed using linear regression models, adjusted for baseline lens status, duration of symptoms, and MLD. Results: A total of 69 eyes of 69 patients with FTMH were included. Mean (± SD) visual acuity was 0.69 ± 0.44 logMAR (Snellen 20/98) before surgery, and improved to 0.39 ± 0.23 logMAR at 6 months after surgery (Snellen 20/49). FTMH closure after a single surgery was 96%. Greater cystoid volume before surgery was associated with larger FTMH MLD ( P < .001), worse preoperative visual acuity ( P = .003), and greater visual acuity improvement at 6 months after surgery ( P = .02). Greater hole asymmetry before surgery was associated with smaller MLD ( P = .04), but not associated with preoperative visual acuity ( P = .74) or postoperative FTMH closure rates ( P = .19). Conclusions: This study on OCT volumetric measurements showed that intraretinal cystoid volume correlated with larger macular holes and greater visual acuity improvement while smaller macular holes tended to be more asymmetric.

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Purpose: To describe patient characteristics, treatment, and pregnancy outcomes in at-risk patients with retinal vascular diseases occurring during pregnancy. Methods: This is a retrospective observational study of pregnant patients seen by a retina specialist or by any ophthalmologist who coded a retinal vascular disease or precursor as the visit diagnosis, at four tertiary care centers. Outcome measures include prevalence of retinal vascular diseases, progression of diabetic retinopathy, treatment of diabetic retinopathy, and adverse pregnancy outcomes. Results: Two hundred nine pregnancies from 176 patients met inclusion criteria. Retinal vascular disease was confirmed in 35% (73 of 209) of pregnancies. Of these, 73% (53) were complicated by diabetic retinopathy, 14% (10) by central serous chorioretinopathy, 11% (8) by hypertensive retinopathy, and 5% (4) by retinal vein occlusion. Twenty-eight percent (16 of 58) of patients with diabetic retinopathy required ophthalmologic treatment during pregnancy or postpartum. Rates of preterm birth (54% vs. 25%, P = 0.0004) and C-section delivery (78% vs. 48%, P = 0.0004) were significantly higher in patients with a retinal vascular disease. Conclusion: Retinal vascular disease was seen in more than one-third of the at-risk pregnancies in this sample and may represent an important obstetric risk factor, as rates of certain adverse pregnancy outcomes were significantly higher in these patients.

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (7)

Samantha Fraser‐Bell

University of Sydney

AUSTRALIA
View details

Romy Bejjani

Harvard University

UNITED STATES
View details

Andreas Pollreisz

Associate Professor

Medical University of Vienna

AUSTRIA
View details

Cagri Besirli

University of Michigan

UNITED STATES
View details

Justis Ehlers

The Norman C. and Donna L. Harbert Endowed Chair for Ophthalmic Research

Cleveland Clinic

UNITED STATES
View details

Sean Berkowitz

Vanderbilt University Medical Center

UNITED STATES
View details

Jennifer I Lim

Vice Chair; Marion H Schenk Chair in Ophthalmolgy, Director of Retina Service

University of Illinois at Chicago College of Medicine

UNITED STATES
View details